Carbapenemase Gene Dynamics in CREC, Guangdong

Carbapenem-resistant Enterobacter cloacae complex is an important but comparatively less characterized component of carbapenem-resistant Enterobacterales surveillance. The study by Chen and colleagues in BMC Microbiology examines how carbapenemase-encoding genes are distributed, mobilized, and associated with resistance phenotypes in clinical isolates collected across Guangdong, China. Its value lies less in identifying a single resistance determinant than in connecting several levels of evidence: gene localization, horizontal transfer, mobile genetic elements, antimicrobial susceptibility, and strain relatedness.

Study Background and Research Question

Carbapenemase-encoding genes can render clinically important β-lactam antibiotics ineffective, while their location on plasmids may facilitate movement between bacterial cells. Chromosomal integration can also stabilize resistance within a lineage. These processes are especially relevant for E. cloacae, an opportunistic pathogen recovered from multiple hospital departments and clinical specimen types.

The authors focused on isolates obtained during the period following the major COVID-19 disruption of healthcare systems. Increased antibiotic exposure, complex infections, and changes in hospital services may alter the ecology of resistant organisms, but the supplied study does not establish a direct pre-pandemic versus pandemic causal comparison. Instead, it asks a more focused question: among carbapenem-resistant E. cloacae collected from eight teaching hospitals between December 2022 and June 2024, which carbapenemase genes are present, where are they located, how readily do they transfer, and do the isolates show evidence of shared transmission?

Key Innovation from the Reference Study

The principal innovation is the integration of molecular epidemiology with a functional transfer assay. According to the reference study, the investigators did not stop after detecting carbapenemase genes by PCR. They used variable-temperature SDS plasmid elimination to distinguish plasmid-associated from chromosomal signals, tested conjugative transfer, identified neighboring mobile genetic elements, measured antimicrobial susceptibility, and grouped isolates by ERIC-PCR and NTSYS analysis.

This combined design helps distinguish three related but different mechanisms of spread. A plasmid-associated gene may move horizontally into a new host. A chromosomal gene may persist through vertical expansion of a successful clone. Mobile elements such as insertion sequences may contribute to gene capture or rearrangement, although their presence alone does not prove a specific transposition event. By examining these layers together, the study provides a more informative picture of transmission dynamics than a prevalence survey based only on resistance phenotype or a single PCR target.

Methods and Experimental Design Insights

The work used 54 carbapenem-resistant E. cloacae isolates collected from eight teaching hospitals in Guangdong over the study interval. The design is clinically grounded: isolates were linked to patient sex, age group, clinical department, and specimen category. This allowed the molecular results to be interpreted alongside the epidemiological context rather than as an isolated laboratory dataset.

Protocol Parameters

• Isolate set: Analyze 54 CREC isolates collected across eight teaching hospitals between December 2022 and June 2024; these are literature-backed study parameters rather than universal requirements for a new experiment. The reference study provides the sampling context.
• Gene detection: Use PCR to screen for carbapenemase-encoding genes after the initial isolate characterization. The reported targets included blaNDM-1, blaIMP, and blaKPC-2.
• Gene localization: Apply variable-temperature SDS plasmid elimination followed by PCR to compare gene detection before and after plasmid curing. Interpret a change in PCR status as evidence supporting plasmid association, while recognizing that curing-based localization is not equivalent to complete genome assembly.
• Susceptibility testing: Use broth microdilution to compare carbapenemase-encoding-gene-positive and -negative groups. The study evaluated imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Conjugation: Perform plasmid conjugation experiments followed by PCR confirmation in recipient cells. The reported transfer outcomes describe the experimental system used by the authors and should not be interpreted as direct estimates of transfer frequency inside patients.
• Strain relatedness: Use ERIC-PCR and NTSYS software to classify the 54 isolates into genotypes. This provides a practical screening approach for relatedness but has lower discriminatory resolution than whole-genome sequencing.
• Mobile-element analysis: Screen for six types of mobile genetic elements and evaluate their co-occurrence with carbapenemase genes. This step supports a mechanistic interpretation of mobility without independently demonstrating the direction or timing of gene movement.

For researchers adapting the workflow, the important methodological principle is sequencing the questions. First establish the resistance-gene profile, then test physical association with plasmids, then assess transfer, and finally examine whether isolates are genetically related. This ordering reduces the risk of treating a correlated phenotype as proof of transmission.

Core Findings and Why They Matter

blaNDM-1 dominated the carbapenemase profile

Carbapenemase-encoding genes were detected in 46 of 54 isolates, corresponding to 85.19% of the collection. Among all isolates, 18 carried blaNDM-1 on both chromosomes and plasmids, while 25 carried blaNDM-1 exclusively on plasmids. Two isolates contained only plasmid-associated blaIMP, and one carried both plasmid-associated blaNDM-1 and blaKPC-2. These proportions are reported in Chen et al..

The dual chromosomal-and-plasmid localization of blaNDM-1 is particularly important. It suggests that the same resistance determinant may be maintained within a bacterial lineage while also remaining available for plasmid-mediated dissemination. The plasmid-only group further indicates that hospital surveillance focused solely on clonal spread could miss a substantial route of horizontal transmission.

Transfer experiments supported substantial mobility

Conjugation experiments produced successful transfer of carbapenemase-encoding genes in 44 of 46 gene-positive isolates, or 95.65%. Transfer was observed for blaNDM-1 in 42 of 44 tested cases, for blaIMP in both tested cases, and not for the single blaKPC-2-containing isolate. These findings support a high transfer potential in the study collection, particularly for blaNDM-1, although the small numbers for blaIMP and blaKPC-2 make gene-specific comparisons unstable.

The result matters operationally because a transferable plasmid can move resistance between strains that are not otherwise closely related. It also reinforces the need to pair infection-control investigations with plasmid and mobile-element analysis rather than relying only on isolate-level species identification.

Mobile elements and strain relatedness added transmission context

ISEcp1 was the most frequently detected mobile genetic element, present in 47 of 54 isolates. Isolates carrying four mobile-element types simultaneously formed the largest combination group, representing 22 of 54 isolates. Such co-occurrence is consistent with a genetic environment capable of assembling or maintaining multiple resistance-associated structures, but it does not by itself establish that ISEcp1 mobilized blaNDM-1 in every isolate.

ERIC-PCR and NTSYS analysis divided the collection into 17 genotypes. Types E and G were each represented by 11 of 54 isolates and appeared in different departments across five hospitals. Within type E, two isolates had a Dice coefficient of 100%. Together, these observations suggest that both interdepartmental or interhospital clonal persistence and independent plasmid dissemination may be occurring. The study therefore supports a mixed transmission model rather than a single outbreak explanation.

Resistance extended beyond carbapenems

The carbapenemase-encoding-gene-positive group showed significantly higher resistance rates than the negative group for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, with statistical significance reported by the authors. Because the condensed findings do not provide every drug-specific resistance percentage or minimum inhibitory concentration distribution, the appropriate interpretation is comparative rather than quantitative.

The levofloxacin result is relevant to the bacterial DNA replication pathway because fluoroquinolones act on bacterial DNA gyrase and related topoisomerase processes. However, the study does not demonstrate that carbapenemase genes directly cause fluoroquinolone resistance. The association may reflect co-resident resistance genes, shared plasmids, permeability changes, efflux, or selection of multidrug-resistant lineages. In an osteoblast growth inhibition assay or other mammalian cell experiment, levofloxacin exposure would address a different biological question and should not be used as a surrogate for carbapenemase activity.

Patient and specimen patterns guide surveillance

The highest detection frequencies occurred among male patients, elderly patients, respiratory medicine cases, and sputum specimens. The reported values were 35 of 54 for male patients, 39 of 54 for the elderly group, 11 of 54 for respiratory medicine, and 18 of 54 for sputum samples, according to the article. These distributions are descriptive, not proof that sex, age, department, or specimen type independently causes CEG carriage. Nevertheless, they can help hospitals prioritize respiratory-care pathways, specimen screening, and review of antibiotic exposure among vulnerable patients.

Comparison with Existing Internal Articles

The internal article Carbapenemase Gene Dynamics in CREC: Insights from Guangdong Hospitals covers the same reference study and is useful as a concise overview of blaNDM-1 predominance, multidrug resistance, and conjugative transfer. The present analysis places greater emphasis on how the experimental components support separate inferences about plasmid mobility, vertical dissemination, and hospital-level relatedness.

For the fluoroquinolone aspect, Levofloxacin in Research: Advanced Protocols & Resistance Insights provides a broader protocol-oriented discussion. Its relevance here is limited but practical: the Guangdong study identifies levofloxacin resistance as part of a wider phenotype, whereas a dedicated Levofloxacin workflow should define exposure conditions, controls, and endpoint measurements independently of carbapenemase-gene detection.

Limitations and Transferability

Several limitations shape how the findings should be transferred to other settings. The sample included only 54 isolates from teaching hospitals in one Chinese province, so prevalence estimates should not be generalized to community populations, non-teaching hospitals, or other geographic regions. The sampling window also supports a contemporary snapshot rather than a longitudinal demonstration of how transmission changed during COVID-19.

The study used PCR and plasmid elimination to infer gene location rather than presenting complete genome and plasmid assemblies. Curing can be incomplete or affect bacterial physiology, and PCR-negative results after treatment may not resolve complex integration states. ERIC-PCR is valuable for rapid comparison but cannot provide the same resolution as whole-genome sequencing for separating recent transmission from shared background. Similarly, in vitro conjugation demonstrates potential transfer under laboratory conditions, not the probability of transfer in a patient, ward, wastewater system, or community reservoir.

Finally, the significant antimicrobial-susceptibility differences identify an association between CEG status and broader resistance, but they do not determine the genetic basis of resistance to each non-carbapenem drug. Future studies would be strengthened by longitudinal sampling, whole-genome sequencing, closed plasmid reconstruction, quantitative transfer measurements, and patient-level exposure data.

Research Support Resources

Researchers designing related susceptibility or bacterial DNA replication pathway experiments can use Levofloxacin (SKU B1959), a synthetic fluoroquinolone antibiotic and DNA gyrase inhibitor, as a defined comparator where scientifically appropriate. The product information lists a molecular weight of 361.37, recommends storage at −20 °C, and advises prompt use of prepared solutions; assay-specific controls and concentration optimization remain necessary. These resources complement, but do not replace, the molecular surveillance and transfer methods reported by Chen et al.